Becton Dickinson And Company Stock News

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Dividend King club is an exclusive one. It takes good management to grow a dividend for 50 or more years, and these two healthcare stocks offer that.

A slew of strategic acquisitions are driving the top line for BD (BDX).

Becton, Dickinson And Co. (BDX) shares closed today at 0.7% below its 52 week high of $264.50, giving the company a market cap of $74B. The stock is currently up 4.4% year-to-date, up 1.7% over the past 12 months, and up 61.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.2%. Trading Activity Trading volume this week was 37.9% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -165.5% The company's stock price performance over the past 12 months lags the peer average by -83.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -36.9% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Becton, Dickinson And Co. (BDX) shares closed today at 0.7% below its 52 week high of $264.50, giving the company a market cap of $74B. The stock is currently up 4.4% year-to-date, up 3.3% over the past 12 months, and up 61.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 27.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -165.5% The company's stock price performance over the past 12 months lags the peer average by -69.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -36.9% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Becton, Dickinson And Co. (BDX) shares closed today at 0.3% below its 52 week high of $264.50, giving the company a market cap of $74B. The stock is currently up 4.1% year-to-date, up 0.9% over the past 12 months, and up 60.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 26.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -178.2% The company's stock price performance over the past 12 months lags the peer average by -92.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -37.8% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Beckton, Dickinson and Company is a Profitable Dividend Aristocrat that generates tons of cash.

The 35 Dividend Kings finished 2021 on a bright note adding 8.79% in December. The 8 best dividend kings based on forecasted growth and valuation trailed the average dividend king return by 161 bps in

Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic buyouts.

Here are some MedTech stocks - Quidel (QDEL), Thermo Fisher (TMO), Baxter (BAX) and BD (BDX) - that have been quite active in the acquisition front and therefore worth investor attention.

FRANKLIN LAKES, N.J., Jan. 5, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its first quarter of fiscal year 2022 on Th

BD (BDX) collaborates with retail partners and distributors to make the BD Veritor At-Home COVID-19 Test widely accessible.

We explain why selling the cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.

Nordea Investment Management AB grew its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 94.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 157,356 shares of the medical instruments supplier’s stock after purchasing an additional 76,623 shares during the period. Nordea Investment Management […] The post Becton, Dickinson and Company (NYSE:BDX) Position Increased by Nordea Investment Management AB appeared first on ETF Daily News .